Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Chaitanya Inampudi"'
Autor:
Jasmine Chen, Aleks C. Guanizo, W. Samantha N. Jakasekara, Chaitanya Inampudi, Quinton Luong, Daniel J. Garama, Muhammad Alamgeer, Nishant Thakur, Michael DeVeer, Vinod Ganju, D. Neil Watkins, Jason E. Cain, Daniel J. Gough
Publikováno v:
Journal of Experimental & Clinical Cancer Research, Vol 42, Iss 1, Pp 1-14 (2023)
Abstract Background Small cell lung cancer (SCLC) is an aggressive neuroendocrine cancer with an appalling overall survival of less than 5% (Zimmerman et al. J Thor Oncol 14:768-83, 2019). Patients typically respond to front line platinum-based doubl
Externí odkaz:
https://doaj.org/article/188977388363466f976932deaf19e20a
Autor:
C. Dilanka Fernando, W. Samantha N. Jayasekara, Chaitanya Inampudi, Maija R.J. Kohonen-Corish, Wendy A. Cooper, Traude H. Beilharz, Tracy M. Josephs, Daniel J. Garama, Daniel J. Gough
Publikováno v:
Cell Reports, Vol 42, Iss 9, Pp 113033- (2023)
Summary: Signal transducer and activator of transcription 3 (STAT3) is a potent transcription factor necessary for life whose activity is corrupted in diverse diseases, including cancer. STAT3 biology was presumed to be entirely dependent on its acti
Externí odkaz:
https://doaj.org/article/0b416294b8d648a2b18c0473e3703a04
Autor:
Aleks C. Guanizo, Daniel J. Gough, Anette Szczepny, D. Neil Watkins, Quinton Luong, Vinod Ganju, Prudence A. Russell, Jasmine Chen, Daniel J. Garama, Dhilshan Jayasinghe, Chaitanya Inampudi, W. Samantha N. Jayasekara, Jason E. Cain
Publikováno v:
Oncogene. 41:138-145
Small cell lung cancer (SCLC) is an aggressive neuroendocrine cancer characterized by loss of function TP53 and RB1 mutations in addition to mutations in other oncogenes including MYC. Overexpression of MYC together with Trp53 and Rb1 loss in pulmona
Publikováno v:
Journal of Neurotrauma. 37:706-723
Traumatic brain injury (TBI) is a major health problem causing disability and death worldwide. There is no effective treatment, due in part to the complexity of the injury pathology and factors affecting its outcome. The extent of brain injury depend
Autor:
Jasmine, Chen, Aleks, Guanizo, Quinton, Luong, W Samantha N, Jayasekara, Dhilshan, Jayasinghe, Chaitanya, Inampudi, Anette, Szczepny, Daniel J, Garama, Prudence A, Russell, Vinod, Ganju, Jason E, Cain, D Neil, Watkins, Daniel J, Gough
Publikováno v:
Oncogene. 41(1)
Small cell lung cancer (SCLC) is an aggressive neuroendocrine cancer characterized by loss of function TP53 and RB1 mutations in addition to mutations in other oncogenes including MYC. Overexpression of MYC together with Trp53 and Rb1 loss in pulmona